Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal
Strategic angle: Neurocrine Biosciences is acquiring Soleno Therapeutics for $2.9 billion, gaining access to a treatment for a rare disease linked to insatiable hunger.
9 articles tagged with "biotechnology"
Strategic angle: Neurocrine Biosciences is acquiring Soleno Therapeutics for $2.9 billion, gaining access to a treatment for a rare disease linked to insatiable hunger.
Strategic angle: A team at Westlake University has developed a new platform to create rapid-acting protein therapeutics.
Strategic angle: This groundbreaking achievement could revolutionize reproductive medicine.
Strategic angle: Exploring the role of enzymes in the biofuels economy and chemical production.
Strategic angle: A novel laser-based system developed by RIKEN researchers can create mesh-like structures that resemble cell cytoskeletons, aiding in protein interaction research.
Strategic angle: A groundbreaking method achieves high efficiency in amino acid synthesis, crucial for biological processes.
Strategic angle: A groundbreaking advancement in gene editing technology enhances precision while reducing unintended changes.
Innovative biotechnological advancements pave the way for more efficient rare-earth element refinement.
Strategic angle: Innovative living cells with olfactory receptors offer a breakthrough in odor detection technology.